EP 0948524 A1 19991013 - PEPTIDES AGONISTS OF BRADYKININE B 2? RECEPTOR
Title (en)
PEPTIDES AGONISTS OF BRADYKININE B 2? RECEPTOR
Title (de)
PEPTIDANTAGONISTEN DES BRADYKININ B2-REZEPTORS
Title (fr)
PEPTIDES AGONISTES DU RECEPTEUR B 2? DE LA BRADYKININE
Publication
Application
Priority
- FR 9702193 W 19971203
- FR 9614890 A 19961204
Abstract (en)
[origin: FR2756566A1] The invention concerns a pseudopeptide compounds selected among the set constituted by (i) the compounds of formula (I) in which: A1 represents a single bond, D-Arg or L-Lys; A2 represents L-Pro or trans-4-hydroxy-L-Pro (4Hyp); A3 represents L-Phe or L-thienylalanine (Thi); Y represents a hydrogen atom or a C1-C3 alkyl group; X represents a sulphur or oxygen atom; and (ii) their additive salts. The invention also concerns the preparation and use of this compound and its additive salts in therapy.
IPC 1-7
IPC 8 full level
A61K 38/00 (2006.01); A61P 9/10 (2006.01); A61P 15/04 (2006.01); A61P 15/08 (2006.01); A61P 43/00 (2006.01); C07K 5/078 (2006.01); C07K 7/18 (2006.01)
CPC (source: EP US)
A61P 9/10 (2017.12 - EP); A61P 15/04 (2017.12 - EP); A61P 15/08 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07K 5/06139 (2013.01 - EP US); C07K 7/18 (2013.01 - EP US); A61K 38/00 (2013.01 - EP US)
Citation (search report)
See references of WO 9824809A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
FR 2756566 A1 19980605; FR 2756566 B1 19990108; CA 2273190 A1 19980611; EP 0948524 A1 19991013; JP 2001505216 A 20010417; US 6316413 B1 20011113; WO 9824809 A1 19980611
DOCDB simple family (application)
FR 9614890 A 19961204; CA 2273190 A 19971203; EP 97948993 A 19971203; FR 9702193 W 19971203; JP 52528598 A 19971203; US 31941799 A 19990604